Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics Debt to Equity Ratio : 0.0118 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0118 |
| June 30, 2026 | 0.0119 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.0255 |
| December 31, 2025 | 0.0218 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5477 |
| Bristol Myers Squibb Co. | 1.915 |
| Harmony Biosciences Holdings, Inc. | 0.2175 |
| ANI Pharmaceuticals, Inc. | 0.9531 |
| Corcept Therapeutics, Inc. | 0.0108 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 417.62M |
| Total Liabilities (Quarterly) | 20.17M |
| Shareholders Equity (Quarterly) | 397.46M |
| Current Ratio | 17.48 |
| Net Debt Paydown Yield | -0.09% |